These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38040422)

  • 1. Cognitive task analysis of clinicians' drug-drug interaction management during patient care and implications for alert design.
    Russ-Jara AL; Elkhadragy N; Arthur KJ; DiIulio JB; Militello LG; Ifeachor AP; Glassman PA; Zillich AJ; Weiner M
    BMJ Open; 2023 Dec; 13(12):e075512. PubMed ID: 38040422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug-drug interaction alerts.
    Baysari MT; Zheng WY; Li L; Westbrook J; Day RO; Hilmer S; Van Dort BA; Hargreaves A; Kennedy P; Monaghan C; Doherty P; Draheim M; Nair L; Samson R
    BMJ Open; 2019 Aug; 9(8):e026034. PubMed ID: 31427312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations to improve the usability of drug-drug interaction clinical decision support alerts.
    Payne TH; Hines LE; Chan RC; Hartman S; Kapusnik-Uner J; Russ AL; Chaffee BW; Hartman C; Tamis V; Galbreth B; Glassman PA; Phansalkar S; van der Sijs H; Gephart SM; Mann G; Strasberg HR; Grizzle AJ; Brown M; Kuperman GJ; Steiner C; Sullins A; Ryan H; Wittie MA; Malone DC
    J Am Med Inform Assoc; 2015 Nov; 22(6):1243-50. PubMed ID: 25829460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Design for Drug-Drug Interaction Alerts Improves Prescribing Efficiency.
    Russ AL; Chen S; Melton BL; Johnson EG; Spina JR; Weiner M; Zillich AJ
    Jt Comm J Qual Patient Saf; 2015 Sep; 41(9):396-405. PubMed ID: 26289234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turning off frequently overridden drug alerts: limited opportunities for doing it safely.
    van der Sijs H; Aarts J; van Gelder T; Berg M; Vulto A
    J Am Med Inform Assoc; 2008; 15(4):439-48. PubMed ID: 18436915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication decision-making for patients with renal insufficiency in inpatient and outpatient care at a US Veterans Affairs Medical Centre: a qualitative, cognitive task analysis.
    Elkhadragy N; Ifeachor AP; Diiulio JB; Arthur KJ; Weiner M; Militello LG; Glassman PA; Zillich AJ; Russ AL
    BMJ Open; 2019 May; 9(5):e027439. PubMed ID: 31129589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barriers to Adoption of Tailored Drug-Drug Interaction Clinical Decision Support.
    Zhang T; Gephart SM; Subbian V; Boyce RD; Villa-Zapata L; Tan MS; Horn J; Gomez-Lumbreras A; Romero AV; Malone DC
    Appl Clin Inform; 2023 Aug; 14(4):779-788. PubMed ID: 37793617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers.
    Ko Y; Malone DC; Skrepnek GH; Armstrong EP; Murphy JE; Abarca J; Rehfeld RA; Reel SJ; Woosley RL
    Drug Saf; 2008; 31(6):525-36. PubMed ID: 18484786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies prescribers and pharmacists use to identify and mitigate adverse drug reactions in inpatient and outpatient care: a cognitive task analysis at a US Veterans Affairs Medical Center.
    Nguyen KA; Militello LG; Ifeachor A; Arthur KJ; Glassman PA; Zillich AJ; Weiner M; Russ-Jara AL
    BMJ Open; 2022 Feb; 12(2):e052401. PubMed ID: 35190423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-priority drug-drug interaction clinical decision support overrides in a newly implemented commercial computerized provider order-entry system: Override appropriateness and adverse drug events.
    Edrees H; Amato MG; Wong A; Seger DL; Bates DW
    J Am Med Inform Assoc; 2020 Jun; 27(6):893-900. PubMed ID: 32337561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Clinical Importance of Drug Interactions Identified by Hospital Pharmacists and a Local Clinical Decision Support System.
    Lau L; Bagri H; Legal M; Dahri K
    Can J Hosp Pharm; 2021; 74(3):203-210. PubMed ID: 34248160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in high-priority drug-drug interaction alerts across institutions and electronic health records.
    McEvoy DS; Sittig DF; Hickman TT; Aaron S; Ai A; Amato M; Bauer DW; Fraser GM; Harper J; Kennemer A; Krall MA; Lehmann CU; Malhotra S; Murphy DR; O'Kelley B; Samal L; Schreiber R; Singh H; Thomas EJ; Vartian CV; Westmorland J; McCoy AB; Wright A
    J Am Med Inform Assoc; 2017 Mar; 24(2):331-338. PubMed ID: 27570216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electronic drug interaction alerts in ambulatory care: the value and acceptance of high-value alerts in US medical practices as assessed by an expert clinical panel.
    Weingart SN; Seger AC; Feola N; Heffernan J; Schiff G; Isaac T
    Drug Saf; 2011 Jul; 34(7):587-93. PubMed ID: 21663334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicians' responses to computerized drug-drug interaction alerts for outpatients.
    Yeh ML; Chang YJ; Wang PY; Li YC; Hsu CY
    Comput Methods Programs Biomed; 2013 Jul; 111(1):17-25. PubMed ID: 23608682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of potential drug interactions in a transplant centre setting and relevance of electronic alerts for clinical practice support.
    Polidori P; Di Giorgio C; Provenzani A
    Inform Prim Care; 2012; 20(4):257-62. PubMed ID: 23890337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical evaluation of clinical decision support for the detection of drug-drug interactions.
    Smithburger PL; Buckley MS; Bejian S; Burenheide K; Kane-Gill SL
    Expert Opin Drug Saf; 2011 Nov; 10(6):871-82. PubMed ID: 21542665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for selecting drug-drug interactions for clinical decision support.
    Tilson H; Hines LE; McEvoy G; Weinstein DM; Hansten PD; Matuszewski K; le Comte M; Higby-Baker S; Hanlon JT; Pezzullo L; Vieson K; Helwig AL; Huang SM; Perre A; Bates DW; Poikonen J; Wittie MA; Grizzle AJ; Brown M; Malone DC
    Am J Health Syst Pharm; 2016 Apr; 73(8):576-85. PubMed ID: 27045070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic Health Record.
    Wright A; Aaron S; Seger DL; Samal L; Schiff GD; Bates DW
    J Gen Intern Med; 2018 Nov; 33(11):1868-1876. PubMed ID: 29766382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicians' Perspectives and Proposed Solutions to Improve Contraceptive Counseling in the United States: Qualitative Semistructured Interview Study With Clinicians From the Society of Family Planning.
    Goueth R; Holt K; Eden KB; Hoffman A
    JMIR Form Res; 2023 Aug; 7():e47298. PubMed ID: 37603407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-drug interaction checking assisted by clinical decision support: a return on investment analysis.
    Helmons PJ; Suijkerbuijk BO; Nannan Panday PV; Kosterink JG
    J Am Med Inform Assoc; 2015 Jul; 22(4):764-72. PubMed ID: 25670751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.